Caplight Directory>Companies>S2 Genomics-preview>S2genomics


S2 Genomics

S2 Genomics

Private
Livermore, CaliforniaHealthcare & Life Scienceshttps://s2genomics.com/

Last Round

Series A

Jan 23, 2024

Total Funding Raised

$16.28M

Company Overview

S2 Genomics is a life science tools company that provides automated tissue sample preparation systems for single-cell genomics and cell biology applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

automated sample prepsingle cell genomicsautomated tissue dissociatortissue dissociationsingle cell sample preplab automationsingle cell suspensionsingle nuclei suspensionlife science toolsbiotech equipmentlab consumablesbenchtop instrumentrazor and blade modelscRNA-SeqsnRNA-Seqoncology researchneuroscience research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

S2 Genomics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

S2 Genomics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 23, 2024
SeedDec 11, 2019
GrantJun 26, 2018
View all Funding Rounds

S2 Genomics Investors

Notable investors and investment history

InvestorRounds
HealthTech CapitalSeed
Research Corporation TechnologiesSeries A
NIH RADxGrant
Life Science AngelsSeed
BroadOak Capital PartnersSeries A
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2025

    Monthly visitors grew 119% MoM, reaching 1.4K.

  • Mar 28, 2024

    Grew 19% QoQ, from 26 to 31 employees.

View all signals

S2 Genomics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

S2 Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about S2 Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLivermore, California
Employee Range6
Year Founded2016
Last FundingJan 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.